These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 9326216)

  • 41. Hematopoietic progenitor cell mobilization into the peripheral blood of mice using a combination of recombinant rat stem cell factor (rrSCF) and recombinant human granulocyte colony-stimulating factor (rhG-CSF).
    Drize N; Chertkov J; Zander A
    Exp Hematol; 1995 Oct; 23(11):1180-6. PubMed ID: 7556528
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The granulocyte colony-stimulating factor receptor supports erythroid differentiation in the absence of the erythropoietin receptor or Stat5.
    Millot GA; Svinarchuk F; Lacout C; Vainchenker W; Dumenil D
    Br J Haematol; 2001 Feb; 112(2):449-58. PubMed ID: 11167846
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Cyclophosphamide/granulocyte colony-stimulating factor causes selective mobilization of bone marrow hematopoietic stem cells into the blood after M phase of the cell cycle.
    Wright DE; Cheshier SH; Wagers AJ; Randall TD; Christensen JL; Weissman IL
    Blood; 2001 Apr; 97(8):2278-85. PubMed ID: 11290588
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Expansion of granulocyte colony-stimulating factor/chemotherapy-mobilized CD34+ hematopoietic progenitors: role of granulocyte-macrophage colony-stimulating factor/erythropoietin hybrid protein (MEN11303) and interleukin-15.
    Pierelli L; Scambia G; Bonanno G; Coscarella A; De Santis R; Mele A; Battaglia A; Fattorossi A; Romeo V; Menichella G; Mancuso S; Leone G
    Exp Hematol; 1999 Mar; 27(3):416-24. PubMed ID: 10089903
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Stromal-derived factor 1 and matrix metalloproteinase 9 levels in bone marrow and peripheral blood of patients mobilized by granulocyte colony-stimulating factor and chemotherapy. Relationship with mobilizing capacity of haematopoietic progenitor cells.
    Carion A; Benboubker L; Hérault O; Roingeard F; Degenne M; Senecal D; Desbois I; Colombat P; Charbord P; Binet C; Domenech J
    Br J Haematol; 2003 Sep; 122(6):918-26. PubMed ID: 12956762
    [TBL] [Abstract][Full Text] [Related]  

  • 46. In situ radiation sensitivity of recombinant human granulocyte colony-stimulating factor-recruited murine circulating blood and bone marrow progenitors (colony-forming unit [CFU]-granulocyte-macrophage and CFU-megakaryocyte): evidence for possible biologic differences between mobilized blood and bone marrow.
    Scheding S; Media JE; KuKuruga MA; Nakeff A
    Blood; 1996 Jul; 88(2):472-8. PubMed ID: 8695794
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Differential role of CD97 in interleukin-8-induced and granulocyte-colony stimulating factor-induced hematopoietic stem and progenitor cell mobilization.
    van Pel M; Hagoort H; Kwakkenbos MJ; Hamann J; Fibbe WE
    Haematologica; 2008 Apr; 93(4):601-4. PubMed ID: 18326527
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Low-dose radiation (LDR) induces hematopoietic hormesis: LDR-induced mobilization of hematopoietic progenitor cells into peripheral blood circulation.
    Li W; Wang G; Cui J; Xue L; Cai L
    Exp Hematol; 2004 Nov; 32(11):1088-96. PubMed ID: 15539087
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Reduced stem cell mobilization in mice receiving antibiotic modulation of the intestinal flora: involvement of endotoxins as cofactors in mobilization.
    Velders GA; van Os R; Hagoort H; Verzaal P; Guiot HF; Lindley IJ; Willemze R; Opdenakker G; Fibbe WE
    Blood; 2004 Jan; 103(1):340-6. PubMed ID: 12969972
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The CXCR4 agonist peptide, CTCE-0021, rapidly mobilizes polymorphonuclear neutrophils and hematopoietic progenitor cells into peripheral blood and synergizes with granulocyte colony-stimulating factor.
    Pelus LM; Bian H; Fukuda S; Wong D; Merzouk A; Salari H
    Exp Hematol; 2005 Mar; 33(3):295-307. PubMed ID: 15730853
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Combining G-CSF with a blockade of adhesion strongly improves the reconstitutive capacity of mobilized hematopoietic progenitor cells.
    Christ O; Kronenwett R; Haas R; Zöller M
    Exp Hematol; 2001 Mar; 29(3):380-90. PubMed ID: 11274767
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Use of matrix metalloproteinase (MMP)-9 knockout mice demonstrates that MMP-9 activity is not absolutely required for G-CSF or Flt-3 ligand-induced hematopoietic progenitor cell mobilization or engraftment.
    Robinson SN; Pisarev VM; Chavez JM; Singh RK; Talmadge JE
    Stem Cells; 2003; 21(4):417-27. PubMed ID: 12832695
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Combination of stem cell factor and granulocyte colony-stimulating factor mobilizes the highest number of primitive haemopoietic progenitors as shown by pre-colony-forming unit (pre-CFU) assay.
    Horsfall MJ; Hui CH; To LB; Begley CG; Basser RL; Simmons PJ
    Br J Haematol; 2000 Jun; 109(4):751-8. PubMed ID: 10929025
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Hematopoietic progenitor cell mobilization in mice by sustained delivery of granulocyte colony-stimulating factor.
    Robinson SN; Chavez JM; Blonder JM; Pisarev VM; Mosley RL; Sang H; Rosenthal GJ; Talmadge JE
    J Interferon Cytokine Res; 2005 Aug; 25(8):490-500. PubMed ID: 16108732
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Biological characterization of CD34+ cells mobilized into peripheral blood.
    Lemoli RM; Tafuri A; Fortuna A; Catani L; Rondelli D; Ratta M; Tura S
    Bone Marrow Transplant; 1998 Dec; 22 Suppl 5():S47-50. PubMed ID: 9989890
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Inhibition of granulocyte colony-stimulating factor-mediated myeloid maturation by low level expression of the differentiation-defective class IV granulocyte colony-stimulating factor receptor isoform.
    White SM; Alarcon MH; Tweardy DJ
    Blood; 2000 Jun; 95(11):3335-40. PubMed ID: 10828013
    [TBL] [Abstract][Full Text] [Related]  

  • 57. CD34+ cells mobilized by cyclophosphamide and granulocyte colony-stimulating factor (G-CSF) are functionally different from CD34+ cells mobilized by G-CSF.
    Cesana C; Carlo-Stella C; Regazzi E; Garau D; Sammarelli G; Caramatti C; Tabilio A; Mangoni L; Rizzoli V
    Bone Marrow Transplant; 1998 Mar; 21(6):561-8. PubMed ID: 9543059
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Increased granulocyte colony-stimulating factor responsiveness but normal resting granulopoiesis in mice carrying a targeted granulocyte colony-stimulating factor receptor mutation derived from a patient with severe congenital neutropenia.
    McLemore ML; Poursine-Laurent J; Link DC
    J Clin Invest; 1998 Aug; 102(3):483-92. PubMed ID: 9691084
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Quantitative and cell-cycle differences in progenitor cells mobilized by recombinant human interleukin-7 and recombinant human granulocyte colony-stimulating factor.
    Grzegorzewski KJ; Komschlies KL; Franco JL; Ruscetti FW; Keller JR; Wiltrout RH
    Blood; 1996 Dec; 88(11):4139-48. PubMed ID: 8943848
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Increase in peripheral blood megakaryocyte progenitors following cancer therapy with high-dose cyclophosphamide and hematopoietic growth factors.
    Siena S; Bregni M; Bonsi L; Sklenar I; Bagnara GP; Bonadonna G; Gianni AM
    Exp Hematol; 1993 Nov; 21(12):1583-90. PubMed ID: 7691640
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.